Coya Therapeutics publishes preclinical study on COYA 303 combination effects
Coya Therapeutics said it has published preclinical results for COYA 303 in the International Journal of Molecular Sciences, describing combination immunomodulatory effects in a model of peripheral and CNS inflammation.